A detailed history of Cloud Capital Management, LLC transactions in Atea Pharmaceuticals, Inc. stock. As of the latest transaction made, Cloud Capital Management, LLC holds 59 shares of AVIR stock, worth $174. This represents 0.0% of its overall portfolio holdings.

Number of Shares
59
Holding current value
$174
% of portfolio
0.0%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 03, 2025

BUY
$2.88 - $3.9 $169 - $230
59 New
59 $0

Others Institutions Holding AVIR

About Atea Pharmaceuticals, Inc.


  • Ticker AVIR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 83,258,600
  • Market Cap $246M
  • Description
  • Atea Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focused on discovering, developing, and commercializing antiviral therapeutics for patients suffering from viral infections. Its lead product candidate is AT-527, an antiviral drug candidate that is in Phase II clinical trial for the treatment of patients with COVID-19. The ...
More about AVIR
Track This Portfolio

Track Cloud Capital Management, LLC Portfolio

Follow Cloud Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cloud Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cloud Capital Management, LLC with notifications on news.